Do the nuances of biological aging make it more difficult for us to develop an HIV cure? Or conversely, could a better understanding of the aging process actually help us advance cure strategies?
To help explore these questions, Alan Landay, PhD, spoke to TheBodyPro at the Conference on Retroviruses and Opportunistic Infections (CROI 2025).
Landay co-authored more than a dozen of the studies presented at CROI 2025. More broadly, his research has been instrumental in understanding the intersection of HIV, aging, and immune function. He is a professor of internal medicine, microbiology, and immunology at the University of Texas Medical Branch. At the university, he also serves as vice president of Team Science and as interim director of the Sealy Center on Aging.
Access the full interview here. It was reviewed by Landay prior to publication.
View all TheBodyPro reports from CROI 2025
Source : TheBodyPro
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.